The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention?

BACKGROUND: To assess the availability, price and market share of quality-assured artemisinin-based combination therapy (QAACT) in remote areas (RAs) compared with non-remote areas (nRAs) in Kenya and Ghana at end-line of the Affordable Medicines Facility-malaria (AMFm) intervention. METHODS: Areas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Malar J
Autors principals: Ye, Yazoume, Arnold, Fred, Noor, Abdisalan, Wamukoya, Marilyn, Amuasi, John, Blay, Samuel, Mberu, Blessing, Ren, Ruilin, Kyobutungi, Catherine, Wekesah, Frederick, Gatakaa, Hellen, Toda, Mitsuru, Njogu, Julius, Evance, Illah, O’Connell, Kathryn, Shewchuk, Tanya, Thougher, Sarah, Mann, Andrea, Willey, Barbara, Goodman, Catherine, Hanson, Kara
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4600285/
https://ncbi.nlm.nih.gov/pubmed/26452625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0904-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars